Biotech Septerna aims to raise up to $186 million in US IPO
Biotechnology company Septerna said on Monday it is aiming to raise up to $186 million in its initial public offering in the United States.
Biotechnology company Septerna said on Monday it is aiming to raise up to $186 million in its initial public offering in the United States.
Incorporating brentuximab vedotin into the treatment of advanced-stage classic Hodgkin’s lymphoma improves outcomes in adult and pediatric patients. However, brentuximab vedotin increases the toxic…
An analysis of 10 popular at-home blood pressure (BP) monitors suggests the arm cuffs don’t properly fit 7% of US adults, approximately 17 million people.…
In the Editorial, Giles Yeo discusses if it is possible that the UPF concept could be doing more harm than good.
The incidence of MASH is on the rise. Learn more about determining risk in your patients and the new and emerging therapies available.
NAR Molecular Medicine is a cutting-edge new journal in the Nucleic Acids Research family portfolio. The journal is fully open access and publishes quality, imp
A “pebble in the shoe” is anything that interferes with patient care. The Southeast Permanente Medical Group has addressed over 200 pebbles.
UnitedHealth Group is in a strong position this Medicare Advantage enrollment period as rivals scale back, CEO Andrew Witty said when announcing quarterly earnings.
Ambulance offload delays can be substantial for patients requiring an acute care bed rather than an ambulatory care setting. Acute care patients were older and…
In the context of marine resource bioprospecting, we construct a bank of culturable marine biofilm bacteria encompassing 713 strains and their nearly complete genomes. Using…
Many vitamins, minerals, and herbs may support decreased blood pressure levels. Here are 14 supplements that may help lower blood pressure.